TL;DR
Oura has agreed to acquire Counsel Health for $625 million in an all-cash transaction, subject to adjustments. The deal would bring AI-supported medical guidance and access to physicians deeper into Oura’s health platform; it is expected to close before the end of 2026.
Oura has agreed to acquire Counsel Health in an all-cash deal valued at $625 million, subject to adjustments, bringing an AI-supported primary care service and access to physicians further into the smart-ring maker’s health platform. The companies said they expect the transaction to close before the end of 2026; until then, the purchase remains an agreement rather than a completed acquisition.
Get comfort and recovery gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Counsel combines artificial intelligence with access to board-certified physicians. Oura and Counsel already have a partnership that began earlier this year. Through the Oura app, members can ask medical questions and receive guidance informed by their health history and Oura data, including sleep, heart rate, activity and recovery measures.
If a user needs care beyond the AI-supported guidance, the service can connect them with a licensed physician. According to the source report, physicians may provide a diagnosis, prescribe medication or recommend additional testing. The service is available through Oura Labs in 43 states, with a reported annual subscription price of $159 for access to medical AI and on-demand physicians.
The companies plan to develop the service across preventive and acute care, as well as chronic-condition management. Areas identified include reproductive health, aging and cardiometabolic conditions. The announcement does not specify how the acquisition will change the current service, its price or eligibility for members.
Oura Adds Physician Access to Its Platform
The agreement would move Oura further from a business centered on wearable devices and membership revenue toward one that also offers routes to medical care. The existing Counsel integration connects information collected by the ring with medical guidance and, when needed, a physician. The acquisition could give Oura more direct control over that connection, although the companies have not detailed the operating model after closing.
For members, the potential appeal is bringing wearable data and clinician access together in one service. But the deal itself does not establish that Oura data can diagnose or prevent illness, nor does it confirm any particular health outcome. Medical decisions remain a matter for qualified clinicians, and the practical value will depend on how the service works, what care it can provide and who can access it.
The purchase may also create new ways for Oura to reach customers beyond its direct membership base. The source report says Counsel has enterprise relationships that could support expansion into employer benefits and healthcare markets. That is a possible business opportunity, not a confirmed distribution plan or revenue forecast. Oura’s scale makes the move consequential: the company reported preliminary fiscal 2026 revenue of about $1.75 billion, up 92% year over year, and more than six million members.
Products Worth Considering
Levoit Core 400S-P Smart Air Purifier for Large Rooms
Dyson Airwrap i.d. Multi-Styler for Straight and Wavy Hair
Bose SoundLink Max Portable Bluetooth Speaker, Black
As an affiliate, we earn on qualifying purchases.
Oura’s Recent Moves Into Care
The Counsel agreement follows several steps that have broadened Oura’s healthcare ambitions. In January, Oura partnered with Fullscript to make biometric trends available, with user consent, through a platform used by more than 125,000 healthcare providers. In April, it teamed with Vida Health to incorporate continuous biometric monitoring into clinician-led metabolic care programs.
In May, Oura introduced features described in the source report as including Health Records, GLP-1 Insights, laboratory result uploads and preventive health monitoring with the launch of Oura Ring 5. Together, these developments show a strategy to connect wearable measurements with health services and clinical workflows, rather than relying only on consumers viewing their own tracking data.
Oura had reportedly been preparing for an initial public offering in the fall, but postponed it in September amid market uncertainty, according to Athletech News. That reported timing provides business context for the acquisition, but the source does not say the IPO delay caused the Counsel deal or explain how the purchase will affect any future listing.
“Oura tells members what’s happening in their bodies, and Counsel helps them act on it.”
— David Shuman, Oura’s executive chairman
Deal Terms and Service Changes Pending
The transaction has been announced but has not closed. The $625 million valuation is subject to adjustments, and the source material does not provide a detailed breakdown of those adjustments, financing arrangements or other closing conditions. The companies have not announced a more specific closing date than before the end of 2026.
It is also unclear whether the acquisition will change Counsel’s $159 annual price, 43-state availability or Oura Labs access, or whether the service will expand to additional states. The companies have not explained how existing Counsel users will be affected, how physician capacity will scale, or what new features will arrive after the deal closes. Any expansion into employer benefits or other healthcare channels remains a possibility described in the report, not a confirmed commitment.
The source does not provide detailed information about how Counsel’s medical AI is evaluated, how clinical oversight is organized, or what rules govern the use of Oura data in care. Those details matter to users, but should not be inferred from the acquisition announcement alone.
Closing and Integration Milestones
The next formal milestone is the companies’ expected closing before the end of 2026. Until completion, Oura and Counsel remain responsible for communicating any changes to their current partnership and service. The companies have not published an integration timetable or a list of features scheduled for release.
Readers can look for further disclosures on final deal terms, service pricing, state availability, physician access and how members’ health information will be used. Oura’s plans for preventive, acute and chronic care, as well as any employer or healthcare-market expansion, will become clearer only if the companies announce specific products, partnerships or launch dates.
Key Questions
What is Oura acquiring?
Oura agreed to acquire Counsel Health, an AI-native primary care company combining medical AI with access to board-certified physicians.
How much is the deal worth?
The companies described the transaction as an all-cash deal valued at $625 million, subject to adjustments. The source report does not provide further detail on those adjustments.
When is the acquisition expected to close?
The companies said they expect the deal to close before the end of 2026. It has not yet been completed.
Can Oura members already use Counsel?
The companies’ existing integration offers access through Oura Labs in 43 states, according to the source report. The reported price is $159 per year for medical AI and on-demand physician access. Whether those terms will change after the acquisition is not yet clear.
What does the deal mean for Oura’s health services?
Oura and Counsel plan to deepen work in preventive and acute care and chronic-condition management, including reproductive health, aging and cardiometabolic conditions. The companies have not yet announced a detailed product or rollout schedule.
Source: athletechnews.com
